Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,499

Sort by:

Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021

US$ 3,000.00

Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021 SUMMARY Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis A...

April 2021 35 pages

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021 SUMMARY MELAS Syndrome (Mitochondrial Encephalomyopathy...

April 2021 35 pages

Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021

US$ 3,000.00

Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021 SUMMARY Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021 provides in depth analysis on Melatonin Receptor...

April 2021 35 pages

Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021

US$ 3,000.00

Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021 SUMMARY Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021 provides in depth analysis on Melatonin Receptor...

April 2021 35 pages

Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC1) - Drugs in Development, 2021

US$ 3,000.00

Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC1) - Drugs in Development, 2021 SUMMARY Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC...

April 2021 40 pages

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

US$ 2,000.00

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Membranoproliferative Glomerulonephritis Type II...

April 2021 35 pages

Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

US$ 2,000.00

Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Developmen...

April 2021 35 pages

Memory Impairment (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Memory Impairment (Central Nervous System) - Drugs in Development, 2021 SUMMARY Memory Impairment (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Memory Impairment pi...

April 2021 35 pages

Meningioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Meningioma (Oncology) - Drugs in Development, 2021 SUMMARY Meningioma (Oncology) - Drugs in Development, 2021 provides an overview of the Meningioma pipeline landscape. The report provides comprehensi...

April 2021 55 pages

Menopausal Disorders (Women's Health) - Drugs in Development, 2021

US$ 2,000.00

Menopausal Disorders (Women's Health) - Drugs in Development, 2021 SUMMARY Menopausal Disorders (Women's Health) - Drugs in Development, 2021 provides an overview of the Menopausal Disorders pipeline...

April 2021 30 pages

Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021

US$ 3,000.00

Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021 SUMMARY Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Dru...

April 2021 35 pages

Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Metabolic Syndrome pipel...

April 2021 60 pages

Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 provides an overview of the...

April 2021 140 pages

Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Bile Duct Cancer...

April 2021 30 pages

Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Biliary Tract Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Biliary T...

April 2021 95 pages

Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Hepatocellular Carcinoma (HCC) (Oncology) - Drugs in Development, 2021 provides an overview of the...

April 2021 115 pages

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Hormone Refractory (Castration Resistant, Androgen...

April 2021 325 pages

Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Liver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Liver Cancer pipeline lan...

April 2021 65 pages

Metastatic Melanoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Metastatic Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Melanoma pipeline landscape. The...

April 2021 425 pages

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeli...

April 2021 115 pages

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Pancreatic Canc...

April 2021 160 pages

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Prostate Cancer pip...

April 2021 95 pages

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Renal Cel...

April 2021 170 pages

Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Transitional (Urothelial) Tract Cancer (Oncology) - Drugs in Development, 2021 provides an...

April 2021 130 pages

Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Uveal Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Uveal Melanoma pipeli...

April 2021 65 pages

Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021

US$ 3,000.00

Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021 SUMMARY Methyl CpG Binding Protein 2 (MECP2) - Drugs in Development, 2021 provides in depth analysis on Methyl CpG Binding Protein 2 (...

April 2021 35 pages

Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Methylmalonic Acidemia (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Methylmalonic Ac...

April 2021 35 pages

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) - Drugs in Development, 2021

US$ 3,000.00

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) - Drugs in Development, 2021 SUMMARY Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomera...

April 2021 30 pages

microRNA 21 (MIR21) - Drugs in Development, 2021

US$ 3,000.00

microRNA 21 (MIR21) - Drugs in Development, 2021 SUMMARY microRNA 21 (MIR21) - Drugs in Development, 2021 provides in depth analysis on microRNA 21 (MIR21) targeted pipeline therapeutics. The report p...

April 2021 30 pages

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) - Drugs in Development, 2021

US$ 3,000.00

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) - Drugs in Development, 2021 SUMMARY Microtubule Associated Protein Tau (Neurofibrillary Tang...

April 2021 150 pages

Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Development, 2021

US$ 3,000.00

Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Development, 2021 SUMMARY Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Developmen...

April 2021 40 pages

Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Mitochondrial Diseases (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Mitochondrial Di...

April 2021 60 pages

Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Mitochondrial Myopathy (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Mito...

April 2021 35 pages

Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine/Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) - Drugs in Development, 2021

US$ 3,000.00

Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine/Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) - Drugs in Development, 2021 SUMMARY Mitogen Activat...

April 2021 30 pages

Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK/ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK/ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Mitog...

April 2021 35 pages

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development, 2021

US$ 3,000.00

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development, 2021 SUMMARY Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development,...

April 2021 35 pages

Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021

US$ 3,000.00

Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021 SUMMARY Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) - Drugs in Development, 2021 provides in depth anal...

April 2021 30 pages

Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021 SUMMARY Molluscum Contagiosum (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Molluscum Contagiosu...

April 2021 35 pages

Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) - Drugs in Development, 2021

US$ 3,000.00

Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) - Drugs in Development, 2021 SUMMARY Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4)...

April 2021 30 pages

Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) - Drugs in Development, 2021

US$ 3,000.00

Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) - Drugs in Development, 2021 SUMMARY Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or...

April 2021 30 pages

Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 SUMMARY Motor Neuron Diseases (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Motor Neuron...

April 2021 30 pages

Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021

US$ 2,000.00

Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021 SUMMARY Mouth and Dental Disorders (Mouth and Dental Disorders) - Drugs in Development, 2021 provides an overview o...

April 2021 30 pages

Movement Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Movement Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Movement Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Movement Disorders...

April 2021 40 pages

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021

US$ 3,500.00

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021 SUMMARY Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OP...

April 2021 325 pages

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021 SUMMARY Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021 pr...

April 2021 30 pages

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) (Genetic Disorders) -...

April 2021 35 pages

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs in Development, 2021

US$ 2,000.00

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs in Development, 2021 SUMMARY Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) (Other Diseases) - Drugs...

April 2021 35 pages

Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021

US$ 3,000.00

Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M1 (CHRM1) - Drugs in Development, 2021 provides in depth analysis on Muscarinic Ace...

April 2021 75 pages

Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021

US$ 3,000.00

Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021 SUMMARY Muscarinic Acetylcholine Receptor M3 (CHRM3) - Drugs in Development, 2021 provides in depth analysis on Muscarinic Ace...

April 2021 65 pages

Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Muscle Atrophy (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Muscle Atrophy pipeline landscape. The r...

April 2021 30 pages

Filters

Clear all